Related Experiment Video

Updated: May 7, 2026

MicroRNA-based Regulation of Picornavirus Tropism
09:05

MicroRNA-based Regulation of Picornavirus Tropism

Published on: February 6, 2017

Anti-tumor activity of a miR-199-dependent oncolytic adenovirus

Elisa Callegari1, Bahaeldin K Elamin, Lucilla D'Abundo

  • 1Dipartimento di Morfologia, Chirurgia e Medicina Sperimentale, Università di Ferrara, Ferrara, Italy.

Plos One
|September 27, 2013
PubMed

Insights

Researchers developed a novel oncolytic adenovirus, Ad-199T, targeting liver cancer. This virus replicates specifically in hepatocellular carcinoma (HCC) cells, offering a potential therapy with reduced liver toxicity.

Area of Science:

  • Oncolytic virotherapy
  • Hepatocellular carcinoma research
  • Molecular virology

Background:

  • MicroRNA-199 (miR-199) is downregulated in hepatocellular carcinoma (HCC).
  • Targeting tumor-specific viral replication can enhance oncolytic adenovirus therapy.
  • Reducing viral replication in normal liver tissue minimizes hepatotoxicity.

Purpose of the Study:

  • To develop a conditionally replication-competent oncolytic adenovirus (Ad-199T) for HCC treatment.
  • To exploit miR-199 downregulation for tumor-specific viral activity.
  • To evaluate the in vivo efficacy and safety of Ad-199T.

Main Methods:

  • Engineered Ad-199T by inserting miR-199 target sites into the E1A gene's 3' UTR.
  • Assessed viral replication and E1A expression in HCC cell lines and normal liver cells.
  • Evaluated Ad-199T's in vivo performance in mouse models (intrahepatic, subcutaneous xenograft, and immune-competent HCC models).

Main Results:

  • Ad-199T exhibited tightly regulated E1A expression and miR-199-dependent replication.
  • Viral replication was inhibited in normal liver tissue, reducing hepatotoxicity.
  • Ad-199T effectively reduced tumor burden in various HCC mouse models.

Conclusions:

  • Ad-199T demonstrates significant therapeutic potential against liver cancer.
  • The engineered oncolytic adenovirus achieves tumor-specific replication and efficacy.
  • Ad-199T offers a promising approach for HCC treatment with a favorable safety profile.

More Related Videos

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice07:02

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

Published on: August 23, 2019

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...